This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Celyn Therapeutics, Inc. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Robert S. Kania
Introduction
Robert S. Kania is a notable inventor based in Del Mar, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of inhibitors for MET receptor tyrosine kinase. His work is crucial for advancing treatments for various diseases.
Latest Patents
Robert S. Kania holds 1 patent related to his research. The patent, titled "Inhibitors of MET kinase," provides innovative compounds that inhibit MET receptor tyrosine kinase. This invention includes pharmaceutical compositions comprising these inhibitory compounds and outlines methods for using them in disease treatment.
Career Highlights
Kania is associated with Celyn Therapeutics, Inc., where he applies his expertise in drug development. His work at the company focuses on creating effective therapies that target critical pathways in disease progression.
Collaborations
Throughout his career, Robert has collaborated with talented professionals, including Toufike Kanouni and John S. Tyhonas. These partnerships have enhanced the research and development efforts at Celyn Therapeutics, Inc.
Conclusion
Robert S. Kania's contributions to the field of pharmaceutical innovation are noteworthy. His work on MET kinase inhibitors exemplifies the impact of dedicated research on improving healthcare outcomes.